Understanding the importance of being informed of the latest trends and developments in a medical world, even a single article can contain lifesaving and crucial information what may be needed anytime. Ultrasound has become a fundamental part of medical practice. Ultrasound is used to diagnose different diseases, so medical practitioners use different types of ultrasound scans, i.e. external, internal, and endoscopic, depending on the part of the body that is examined.
A number of researches and advances have been made in the sphere of ultrasound-based diagnostics and therapy, starting from cancer study to Parkinson's disease research. Past month was full of important events and news, that you might be missed in a daily overloaded news feed. So we have carefully selected some of the news, that will definitely interest you.
July 13, 2018
Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to improve the targeting of cancer drugs to tumours.
The new technology has been used in humans for the very first time, with ultrasound remotely triggering and enhancing the delivery of a cancer drug to the tumour.
July 2, 2018
A new ultrasound system that uses optical, instead of electronic components, could improve performance while giving doctors significantly more flexibility in how they use ultrasound to diagnose and treat medical problems.
"All-optical ultrasound imaging probes have the potential to revolutionize image-guided interventions," said Erwin J. Alles, University College London, United Kingdom. "A lack of electronics and the resulting MRI compatibility will allow for true multi modality image guidance, with probes that are potentially just a fraction of the cost of conventional electronic counterparts."
JULY 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.
By the time Parkinson’s disease patients are diagnosed — typically based on the tremors and motor-control symptoms most associated with the disease — about 60 percent of them also have serious damage to the heart’s connections to the sympathetic nervous system. When healthy, those nerves spur the heart to accelerate its pumping to match quick changes in activity and blood pressure.
July 10, 2018
For the first time, researchers at the University of Oxford used an ultrasound to remotely trigger and enhance the chemotherapy medication into human tissue. Their findings were published Monday in the journal The Lancet Oncology.
"It is possible to safely trigger and target the delivery of chemotherapy deep within the body from outside the body using focused ultrasound," Coussios said. "Once inside the tumor, the drug is released from the carrier, supplying a higher dose of chemotherapy directly to the tumor, which may help to treat tumors more effectively for the same or a lower systemic dose of the drug."
Comments will be approved before showing up.